id,heavy_seq,light_seq,flags_total,flag_category,label,flag_self_interaction,flag_chromatography,flag_polyreactivity,flag_stability,source,smp,ova,bvp_elisa,psr_smp,acsins_dlmax_nm,csi_bli_nm,cic_min,hic_min,smac_min,sgac_sins_mM,as_slope_pct_per_day,hek_titer_mg_per_L,fab_tm_celsius,heavy_seq_length,light_seq_length,Light chain class,Type,Original mAb Isotype or Format,Clinical Status,Phagec,Year Name Proposed,Unnamed: 7,Notes,elisa_fold,bvp_elisa_fold
abituzumab,QVQLQQSGGELAKPGASVKVSCKASGYTFSSFWMHWVRQAPGQGLEWIGYINPRSGYTEYNEIFRDKATMTTDTSTSTAYMELSSLRSEDTAVYYCASFLGRGAMDYWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLAWYQQKPGKAPKLLIYYTSKIHSGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQGNTFPYTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.1666661335637766,1.1373747390491518,2.7207986688851915,0.1666661335637766,1.4588608195349846,0.0,8.620999999999997,9.227,8.725,900.0,0.05563,89.5554580290071,75.5,118,107,kappa,ZU,IgG2,Phase 2,No,2013,,a Made with human isotype,1.1373747390491518,2.7207986688851915
abrilumab,QVQLVQSGAEVKKPGASVKVSCKVSGYTLSDLSIHWVRQAPGKGLEWMGGFDPQDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCATGSSSSWFDPWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCQQANSFPWTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.124623995718366,1.8183028286189689,0.0,-0.9285255875093592,-0.02,8.383999999999999,9.413,8.699,900.0,0.02829,100.223196340551,71.0,118,107,kappa,HU,IgG2,Phase 2,No,2014,,"b Mixed chimeric, humanized LC and HC",1.124623995718366,1.8183028286189689
adalimumab,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQRYNRAPYTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.0755145072525718,1.4881863560732114,0.0,1.062328361664409,-0.01,8.865000000000002,8.816,8.672,900.0,0.05069,134.928638213675,71.0,121,107,kappa,HU,IgG1,Approved,Yes,1999,,c Most as those molecules labeled Yes in the phage column were discovered and or optimized by phage display.  A small number of these were optimized by fragment-based phage techniques not involving display.,1.0755145072525718,1.4881863560732114
alemtuzumab,QVQLQESGPGLVRPSQTLSLTCTVSGFTFTDFYMNWVRQPPGRGLEWIGFIRDKAKGYTTEYNPSVKGRVTMLVDTSKNQFSLRLSSVTAADTAVYYCAREGHTAAPFDYWGQGSLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKLLIYNTNNLQTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCLQHISRPRTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.1614913553524202,1.4642262895174707,0.0,-0.7891989854609082,-0.02,8.513999999999998,8.769,8.672,1000.0,0.06431,144.653542801851,74.5,121,107,kappa,ZU,IgG1,Approved,No,2000,,,1.1614913553524202,1.4642262895174707
alirocumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFNNYAMNWVRQAPGKGLDWVSTISGSGGTTNYADSVKGRFIISRDSSKHTLYLQMNSLRAEDTAVYYCAKDSNWGNFDLWGRGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYRSNNRNFLGWYQQKPGQPPNLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYTTPYTFGQGTKLEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.1962236913634507,2.179700499168053,0.0,1.2305105389538458,-0.01,8.757,9.036,8.681,900.0,0.0292,69.2323451150256,71.5,118,113,kappa,HU,IgG1,Approved,No,2012,,,1.1962236913634507,2.179700499168053
anifrolumab,EVQLVQSGAEVKKPGESLKISCKGSGYIFTNYWIAWVRQMPGKGLESMGIIYPGDSDIRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARHDIEGFDYWGRGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFFAWYQQKPGQAPRLLIYGASSRATGIPDRLSGSGSGTDFTLTITRLEPEDFAVYYCQQYDSSAITFGQGTRLEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.157449676152755,1.6232945091514144,0.0,-0.5613971335854627,-0.02,8.488999999999999,8.799,8.629,700.0,0.0708,82.046820982102,62.5,117,108,kappa,HU,IgG1,Phase 3,No,2013,,,1.157449676152755,1.6232945091514144
atezolizumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDSWIHWVRQAPGKGLEWVAWISPYGGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARRHWPGGFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDVSTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYLYHPATFGQGTKVEIK,3,mild,,True,True,True,False,jain2017,0.0658123841612219,1.2947458411000836,6.1973782771535575,0.0658123841612219,14.97112171419135,0.06,10.759999999999996,13.353,19.283,300.0,0.0556,164.085804300914,73.5,118,107,kappa,ZU,IgG1-no-glyco,Approved,Yes,2014,,,1.2947458411000836,6.1973782771535575
bimagrumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSSYINWVRQAPGQGLEWMGTINPVSGSTSYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGGWFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNYVNWYQQHPGKAPKLMIYGVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCGTFAGGSYYGVFGGGTKLTVL,4,non_specific,1.0,True,True,True,True,jain2017,0.6965555618675863,1.5486084368278836,5.327787021630615,0.6965555618675863,29.64509490013043,0.1,12.328,10.125,8.829,0.0,0.09126,150.238850504352,72.0,115,111,lambda,HU,IgG1,Phase 3,Yes,2012,,,1.5486084368278836,5.327787021630615
blosozumab,QVQLVQSGAEVKKPGASVKVSCKVSGFPIKDTFQHWVRQAPGKGLEWMGWSDPEIGDTEYASKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATGDTTYKFDFWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVHTAVAWYQQKPGKAPKLLIYWASTRWTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSDYPWTFGGGTKVEIK,3,mild,,True,False,True,True,jain2017,0.2082434217055435,13.177765048787675,12.84792013311148,0.2082434217055435,11.472475883134644,0.46,8.866000000000001,9.241,8.626,600.0,0.1252,120.00975163796,70.5,118,107,kappa,ZU,IgG4-CPPC,Phase 2,Yes,2011,,,13.177765048787675,12.84792013311148
bococizumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGEISPFGGRTNYNEKFKSRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARERPLYASDLWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQRYSLWRTFGQGTKLEIK,3,mild,,True,True,True,False,jain2017,0.7601842867698116,13.49645762735782,18.87720465890183,0.7601842867698116,29.64509490013043,0.5,10.595,10.179,9.108,0.0,0.067,95.7869214399117,67.0,118,107,kappa,ZU,IgG2,Phase 3,Yes,2013,,,13.49645762735782,18.87720465890183
briakinumab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAFIRYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCKTHGSHDNWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTISCSGSRSNIGSNTVKWYQQLPGTAPKLLIYYNDQRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDRYTHPALLFGTGTKVTVL,4,non_specific,1.0,True,True,True,True,jain2017,0.5560592534086306,4.829995936621175,10.217637271214642,0.5560592534086306,29.64509490013043,0.02,10.394,9.359,8.737,0.0,0.1054,121.99223381709,71.5,115,111,lambda,HU,IgG1,Phase 3,Yes,2009,,,4.829995936621175,10.217637271214642
brodalumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTRYGISWVRQAPGQGLEWMGWISTYSGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARRQLYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWFQQKPGQAPRPLIYDASTRATGVPARFSGSGSGTDFTLTISSLQSEDFAVYYCQQYDNWPLTFGGGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.2654903000693104,1.4751250398765592,2.9257903494176376,0.2654903000693104,11.207608587538331,-0.01,8.971000000000002,9.079,8.743,900.0,0.01717,150.86258566485,74.5,116,107,kappa,HU,IgG2,Phase 3,No,2011,,,1.4751250398765592,2.9257903494176376
canakinumab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSVYGMNWVRQAPGKGLEWVAIIWYDGDNQYYADSVKGRFTISRDNSKNTLYLQMNGLRAEDTAVYYCARDLRTGPFDYWGQGTLVTVSS,EIVLTQSPDFQSVTPKEKVTITCRASQSIGSSLHWYQQKPDQSPKLLIKYASQSFSGVPSRFSGSGSGTDFTLTINSLEAEDAAAYYCHQSSSLPFTFGPGTKVDIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.1954184187031964,2.545757071547422,0.0,0.6699380678068486,0.0,8.635,9.321,8.727,800.0,0.03791,45.7249289561313,72.0,118,107,kappa,HU,IgG1,Approved,No,2007,,,1.1954184187031964,2.545757071547422
certolizumab,EVQLVESGGGLVQPGGSLRLSCAASGYVFTDYGMNWVRQAPGKGLEWMGWINTYIGEPIYADSVKGRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCARGYRSYAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQNVGTNVAWYQQKPGKAPKALIYSASFLYSGVPYRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNIYPLTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.1438183996579112,1.647920133111481,0.0,0.1630953670850959,-0.01,9.313999999999998,11.478,10.815,500.0,0.04289,186.709368605726,81.5,118,107,kappa,ZU,FabPEG,Approved,No,2004,,,1.1438183996579112,1.647920133111481
cetuximab,QVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVSA,DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.0932803630555306,1.0855241264559068,0.0,1.2999612612528957,-0.04,8.906,10.11,8.91,400.0,0.05474,109.160445482209,68.5,119,107,kappa,XI,IgG1,Approved,No,1999,,,1.0932803630555306,1.0855241264559068
cixutumumab,EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARAPLRFLEWSTQDHYYYYYMDVWGKGTTVTVSS,SSELTQDPAVSVALGQTVRITCQGDSLRSYYATWYQQKPGQAPILVIYGENKRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCKSRDGSGQHLVFGGGTKLTVL,4,non_specific,1.0,True,True,True,True,jain2017,0.6570238935398882,3.766344319771545,11.90415973377704,0.6570238935398882,29.64509490013043,0.38,9.664,11.76,10.723,0.0,0.1617,154.259630219969,73.5,130,108,lambda,HU,IgG1,Phase 2,Yes,2008,,,3.766344319771545,11.90415973377704
clazakizumab,EVQLVESGGGLVQPGGSLRLSCAASGFSLSNYYVTWVRQAPGKGLEWVGIIYGSDETAYATSAIGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDDSSDWDAKFNLWGQGTLVTVSS,AIQMTQSPSSLSASVGDRVTITCQASQSINNELSWYQQKPGKAPKLLIYRASTLASGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQGYSLRNIDNAFGGGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.2815538046885984,4.1151414309484196,0.0,0.9300457109314908,-0.03,8.729000000000001,9.568,8.871,800.0,0.05306,113.477346572884,69.5,120,110,kappa,ZU,IgG1,Phase 2,No,2012,,,1.2815538046885984,4.1151414309484196
crenezumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMSWVRQAPGKGLELVASINSNGGSTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASGDYWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLVYSNGDTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.1049360677631279,1.1333962139863132,2.7806988352745425,0.1049360677631279,6.37079988498525,0.0,8.899,10.031,8.703,700.0,0.04786,149.265976775631,72.0,112,112,kappa,ZU,IgG4-CPPC,Phase 3,No,2011,,,1.1333962139863132,2.7806988352745425
dacetuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYSFTGYYIHWVRQAPGKGLEWVARVIPNAGGTSYNQKFKGRFTLSVDNSKNTAYLQMNSLRAEDTAVYYCAREGIYWWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRSSQSLVHSNGNTFLHWYQQKPGKAPKLLIYTVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCSQTTHVPWTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.0793259925499534,1.3352059925093631,0.0,-0.0146761667615086,-0.04,8.466999999999999,8.466,8.614,1000.0,0.0033,128.4522155567586,68.0,114,112,kappa,ZU,IgG1,Phase 2,No,2007,,,1.0793259925499534,1.3352059925093631
daclizumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYRMHWVRQAPGQGLEWIGYINPSTGYTEYNQKFKDKATITADESTNTAYMELSSLRSEDTAVYYCARGGGVFDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCSASSSISYMHWYQQKPGKAPKLLIYTTSNLASGVPARFSGSGSGTEFTLTISSLQPDDFATYYCHQRSTYPLTFGQGTKVEVK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.1803655455457376,1.4143094841930115,0.0,-0.11058643018373,-0.02,8.476,9.286,8.751,900.0,0.02794,245.10792344452,74.0,116,106,kappa,ZU,IgG1,Approved,No,1994,,,1.1803655455457376,1.4143094841930115
dalotuzumab,QVQLQESGPGLVKPSETLSLTCTVSGYSITGGYLWNWIRQPPGKGLEWIGYISYDGTNNYKPSLKDRVTISRDTSKNQFSLKLSSVTAADTAVYYCARYGRVFFDYWGQGTLVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSIVHSNGNTYLQWYLQKPGQSPQLLIYKVSNRLYGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPWTFGQGTKVEIK,3,mild,,True,False,True,True,jain2017,0.3996481249533758,2.8986549663190946,8.253577371048253,0.3996481249533758,13.680590019875655,0.14,9.118,9.891,8.704,800.0,0.1466,82.4173401920308,77.0,117,112,kappa,ZU,IgG1,Phase 2,No,2009,,,2.8986549663190946,8.253577371048253
daratumumab,EVQLLESGGGLVQPGGSLRLSCAVSGFTFNSFAMSWVRQAPGKGLEWVSAISGSGGGTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCAKDKILWFGEPVFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.2135841080988004,3.151414309484193,0.0,1.80923047610872,0.0,8.854999999999999,9.514,8.926,800.0,0.06363,233.33429841855,71.0,122,107,kappa,HU,IgG1,Approved,No,2009,,,1.2135841080988004,3.151414309484193
duligotuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFTLSGDWIHWVRQAPGKGLEWVGEISAAGGYTDYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARESRVSFEAAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQNIATDVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSEPEPYTFGQGTKVEIK,3,mild,,True,True,True,False,jain2017,0.3344399631930372,8.539747695728627,9.630615640599002,0.3344399631930372,29.64509490013043,0.6,9.53,10.206,8.938,0.0,0.05514,192.582804385907,67.5,121,107,kappa,ZU,IgG1,Phase 2,Yes,2012,,,8.539747695728627,9.630615640599002
eculizumab,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYFFGSSPNWYFDVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,0.9594280678530324,2.99550561797752,0.0,0.043333,-0.04,8.498999999999999,10.41,9.277,700.0,0.008,226.468531780092,66.0,122,107,kappa,ZU,IgG24,Approved,No,2002,,,0.9594280678530324,2.99550561797752
efalizumab,EVQLVESGGGLVQPGGSLRLSCAASGYSFTGHWMNWVRQAPGKGLEWVGMIHPSDSETRYNQKFKDRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARGIYFYGTTYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASKTISKYLAWYQQKPGKAPKLLIYSGSTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHNEYPLTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,0.9829102702195124,1.238202247191011,0.0,0.681275549075847,-0.02,8.541999999999998,8.668,8.641,900.0,0.0,166.9923436829148,72.5,121,107,kappa,ZU,IgG1,Approved,No,2001,,,0.9829102702195124,1.238202247191011
eldelumab,QMQLVESGGGVVQPGRSLRLSCTASGFTFSNNGMHWVRQAPGKGLEWVAVIWFDGMNKFYVDSVKGRFTISRDNSKNTLYLEMNSLRAEDTAIYYCAREGDGSGIYYYYGMDVWGQGTTVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPIFTFGPGTKVDIK,3,mild,,True,True,False,True,jain2017,0.0,1.1090934181246197,1.7470881863560732,0.0,1.2125200258514,-0.02,10.155999999999995,12.422,25.0,500.0,0.0998,89.2530533728545,59.5,124,109,kappa,HU,IgG1,Phase 2,No,2013,,,1.1090934181246197,1.7470881863560732
elotuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPDSSTINYAPSLKDKFIISRDNAKNSLYLQMNSLRAEDTAVYYCARPDGNYWYFDVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVGIAVAWYQQKPGKVPKLLIYWASTRHTGVPDRFSGSGSGTDFTLTISSLQPEDVATYYCQQYSSYPYTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,0.978041767984992,1.2647940074906368,0.0,-0.2244689102300673,-0.03,8.469,10.314,9.288,700.0,0.0,213.190600445939,83.5,119,107,kappa,ZU,IgG1,Approved,No,2008,,,0.978041767984992,1.2647940074906368
emibetuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGRVNPNRRGTTYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARANWLDYWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCSVSSSVSSIYLHWYQQKPGKAPKLLIYSTSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQVYSGYPLTFGGGTKVEIK,3,mild,,True,True,True,False,jain2017,0.6431427690118359,3.3000830869543307,8.32945091514143,0.6431427690118359,29.64509490013043,0.06,9.528,9.638,8.684,0.0,0.04114,98.7489181018493,71.5,115,108,kappa,ZU,IgG4-CPPC,Phase 2,Yes,2014,,,3.3000830869543307,8.32945091514143
epratuzumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYWLHWVRQAPGQGLEWIGYINPRNDYTEYNQNFKDKATITADESTNTAYMELSSLRSEDTAFYFCARRDITTFYWGQGTTVTVSS,DIQLTQSPSSLSASVGDRVTMSCKSSQSVLYSANHKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCHQYLSSWTFGGGTKLEIK,0,specific,0.0,False,False,False,False,jain2017,0.130914724386105,1.4745521259964696,2.3427620632279536,0.130914724386105,3.0141872185730136,-0.01,8.688999999999998,9.189,8.629,900.0,0.02629,78.2305721688696,65.0,116,112,kappa,ZU,IgG1,Phase 3,No,1999,,,1.4745521259964696,2.3427620632279536
etrolizumab,EVQLVESGGGLVQPGGSLRLSCAASGFFITNNYWGWVRQAPGKGLEWVGYISYSGSTSYNPSLKSRFTISRDTSKNTFYLQMNSLRAEDTAVYYCARTGSSGYFDFWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASESVDDLLHWYQQKPGKAPKLLIKYASQSISGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGNSLPNTFGQGTKVEIK,3,mild,,True,False,True,True,jain2017,0.4203780747334936,2.18207134775561,4.228951747088186,0.4203780747334936,2.01764560912522,-0.03,8.767999999999999,9.322,8.77,900.0,0.2009,173.842456075648,76.0,117,107,kappa,ZU,IgG1,Phase 2,Yes,2010,,,2.18207134775561,4.228951747088186
evolocumab,EVQLVQSGAEVKKPGASVKVSCKASGYTLTSYGISWVRQAPGQGLEWMGWVSFYNGNTNYAQKLQGRGTMTTDPSTSTAYMELRSLRSDDTAVYYCARGYGMDVWGQGTTVTVSS,ESALTQPASVSGSPGQSITISCTGTSSDVGGYNSVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCNSYTSTSMVFGGGTKLTVL,0,specific,0.0,False,False,False,False,jain2017,0.2043329600246225,1.7544526538610823,1.7544093178036606,0.2043329600246225,2.236430607880717,-0.01,9.254,10.355,9.13,700.0,0.0298,260.677127753984,65.0,115,109,lambda,HU,IgG2,Approved,No,2012,,,1.7544526538610823,1.7544093178036606
farletuzumab,EVQLVESGGGVVQPGRSLRLSCSASGFTFSGYGLSWVRQAPGKGLEWVAMISSGGSYTYYADSVKGRFAISRDNAKNTLFLQMDSLRPEDTGVYFCARHGDDPAWFAYWGQGTPVTVSS,DIQLTQSPSSLSASVGDRVTITCSVSSSISSNNLHWYQQKPGKAPKPWIYGTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSYPYMYTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.073797051762033,1.3217970049916803,0.0,-0.5019252748286357,-0.01,8.687,9.491,9.065,800.0,0.006029,220.817623863655,75.5,119,110,kappa,ZU,IgG1,Phase 3,No,2008,,,1.073797051762033,1.3217970049916803
fasinumab,QVQLVQSGAEVKKPGASVKVSCKVSGFTLTELSIHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMELTSLRSEDTAVYYCSTIFGVVTNFDNWGQGTLVTVSS,DIQMTQSPSSLSASAGDRVTITCRASQAIRNDLGWYQQKPGKAPKRLIYAAFNLQSGVPSRFSGSGSGTEFTLTISSLQPEDLASYYCQQYNRYPWTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.1568614093693428,2.5271214642262896,0.0,-0.6719270715475414,-0.02,8.358999999999996,10.026,8.715,900.0,0.06657,110.37448729273,71.0,119,107,kappa,HU,IgG4-CPPC,Phase 3,No,2012,,,1.1568614093693428,2.5271214642262896
ficlatuzumab,QVQLVQPGAEVKKPGTSVKLSCKASGYTFTTYWMHWVRQAPGQGLEWIGEINPTNGHTNYNQKFQGRATLTVDKSTSTAYMELSSLRSEDTAVYYCARNYVGSIFDYWGQGTLLTVSS,DIVMTQSPDSLAMSLGERVTLNCKASENVVSYVSWYQQKPGQSPKLLIYGASNRESGVPDRFSGSGSATDFTLTISSVQAEDVADYHCGQSYNYPYTFGQGTKLEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.1338843592183554,1.2332778702163063,0.0,-0.8937858080471764,-0.02,8.488000000000001,9.421,8.882,900.0,0.04614,249.025765193707,75.0,118,107,kappa,ZU,IgG1,Phase 2,No,2011,,,1.1338843592183554,1.2332778702163063
figitumumab,EVQLLESGGGLVQPGGSLRLSCTASGFTFSSYAMNWVRQAPGKGLEWVSAISGSGGTTFYADSVKGRFTISRDNSRTTLYLQMNSLRAEDTAVYYCAKDLGWSDSYYYYYGMDVWGQGTTVTVSS,DIQMTQFPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKRLIYAASRLHRGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNSYPCSFGQGTKLEIK,3,mild,,True,True,True,False,jain2017,0.3789575040877738,2.893762036891925,5.650582362728786,0.3789575040877738,29.64509490013043,0.02,10.533,10.745,9.86,0.0,0.06446,119.916767611708,66.5,125,107,kappa,HU,IgG2,Phase 3,No,2008,,,2.893762036891925,5.650582362728786
fletikumab,QVQLVQSGAEVKRPGASVKVSCKASGYTFTNDIIHWVRQAPGQRLEWMGWINAGYGNTQYSQNFQDRVSITRDTSASTAYMELISLRSEDTAVYYCAREPLWFGESSPHDYYGMDVWGQGTTVTVSS,AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.024451224557659,1.4083194675540764,0.0,-0.1254578092934176,-0.02,8.473999999999998,11.038,9.143,700.0,0.01897,220.376225219369,71.5,127,107,kappa,HU,IgG4-CPPC,Phase 2,No,2013,,,1.024451224557659,1.4083194675540764
foralumab,QVQLVESGGGVVQPGRSLRLSCAASGFKFSGYGMHWVRQAPGKGLEWVAVIWYDGSKKYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARQMGYWHFDLWGRGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPLTFGGGTKVEIK,3,mild,,True,True,True,False,jain2017,0.3717153840610422,4.767633761341637,4.711480865224626,0.3717153840610422,28.085284038746863,0.0,9.324,9.842,8.574,0.0,0.03766,174.435087528376,66.0,118,108,kappa,HU,IgG1,Phase 2,No,2010,,,4.767633761341637,4.711480865224626
fresolimumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFSSNVISWVRQAPGQGLEWMGGVIPIVDIANYAQRFKGRVTITADESTSTTYMELSSLRSEDTAVYYCASTLGLVLDAMDYWGQGTLVTVSS,ETVLTQSPGTLSLSPGERATLSCRASQSLGSSYLAWYQQKPGQAPRLLIYGASSRAPGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYADSPITFGQGTRLEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.3001810808363088,3.5128119800332778,0.0,-0.5150833213308835,-0.02,8.466,10.875,9.145,700.0,0.05526,166.036557375438,74.0,120,108,kappa,HU,IgG4,Phase 2,Yes,2009,,,1.3001810808363088,3.5128119800332778
gevokizumab,QVQLQESGPGLVKPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDGDESYNPSLKSRLTISKDTSKNQVSLKITSVTAADTAVYFCARNRYDPPWFVDWGQGTLVTVSS,DIQMTQSTSSLSASVGDRVTITCRASQDISNYLSWYQQKPGKAVKLLIYYTSKLHSGVPSRFSGSGSGTDYTLTISSLQQEDFATYFCLQGKMLPWTFGQGTKLEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.1800797913129024,1.9314475873544092,0.0,-0.5147700660009676,-0.03,8.578999999999999,8.828,8.607,1000.0,0.07129,136.360640752103,71.5,120,107,kappa,ZU,IgG2,Phase 3,No,2010,,,1.1800797913129024,1.9314475873544092
girentuximab,DVKLVESGGGLVKLGGSLKLSCAASGFTFSNYYMSWVRQTPEKRLELVAAINSDGGITYYLDTVKGRFTISRDNAKNTLYLQMSSLKSEDTALFYCARHRSGYFSMDYWGQGTSVTVSS,DIVMTQSQRFMSTTVGDRVSITCKASQNVVSAVAWYQQKPGQSPKLLIYSASNRYTGVPDRFTGSGSGTDFTLTISNMQSEDLADFFCQQYSNYPWTFGGGTKLEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.0901430323375536,1.393677204658902,0.0,-0.7518211058788499,-0.04,8.524000000000001,9.081,8.683,1000.0,0.03154,30.721829915697,63.0,119,107,kappa,XI,IgG1,Phase 3,No,2009,,,1.0901430323375536,1.393677204658902
glembatumumab,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSFNYYWSWIRHHPGKGLEWIGYIYYSGSTYSNPSLKSRVTISVDTSKNQFSLTLSSVTAADTAVYYCARGYNWNYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVDNNLVWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKVEIK,3,mild,,True,True,False,True,jain2017,0.166106669274089,1.0632913221183808,2.215355805243446,0.166106669274089,28.880634956572568,0.01,13.5,13.68,25.0,0.0,0.303,152.7123452567094,70.5,119,108,kappa,HU,IgG2,Phase 2,No,2009,,,1.0632913221183808,2.215355805243446
guselkumab,EVQLVQSGAEVKKPGESLKISCKGSGYSFSNYWIGWVRQMPGKGLEWMGIIDPSNSYTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARWYYKPFDVWGQGTLVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGYDVHWYQQLPGTAPKLLIYGNSKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCASWTDGLSLVVFGGGTKLTVL,3,mild,,True,False,True,True,jain2017,0.4693386329324933,1.541175938153107,5.867554076539101,0.4693386329324933,3.3671961867062934,0.02,10.109,11.403,9.195,700.0,0.1931,167.340128579443,69.5,117,111,lambda,HU,IgG1,Phase 3,Yes,2013,,,1.541175938153107,5.867554076539101
ibalizumab,QVQLQQSGPEVVKPGASVKMSCKASGYTFTSYVIHWVRQKPGQGLDWIGYINPYNDGTDYDEKFKGKATLTSDTSTSTAYMELSSLRSEDTAVYYCAREKDNYATGAWFAYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERVTMNCKSSQSLLYSTNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSVQAEDVAVYYCQQYYSYRTFGGGTKLEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,0.9931422443300496,1.1262172284644194,0.0,-0.3393042568130033,-0.03,8.659999999999997,10.237,9.771,800.0,0.0393,133.2826330317606,72.0,122,112,kappa,ZU,IgG4,Phase 3,No,2007,,,0.9931422443300496,1.1262172284644194
infliximab,EVKLEESGGGLVQPGGSMKLSCVASGFIFSNHWMNWVRQSPEKGLEWVAEIRSKSINSATHYAESVKGRFTISRDDSKSAVYLQMTDLRTEDTGVYYCSRNYYGSTYDYWGQGTTLTVSS,DILLTQSPAILSVSPGERVSFSCRASQFVGSSIHWYQQRTNGSPRLLIKYASESMSGIPSRFSGSGSGTDFTLSINTVESEDIADYYCQQSHSWPFTFGSGTNLEVK,3,mild,,True,True,False,True,jain2017,0.0,1.03683210868708,1.3717138103161397,0.0,29.64509490013043,0.05,9.011,10.36,8.888,0.0,0.1812,6.58114599258111,64.5,120,107,kappa,XI,IgG1,Approved,No,1997,,,1.03683210868708,1.3717138103161397
ixekizumab,QVQLVQSGAEVKKPGSSVKVSCKASGYSFTDYHIHWVRQAPGQGLEWMGVINPMYGTTDYNQRFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDYFTGTGVYWGQGTLVTVSS,DIVMTQTPLSLSVTPGQPASISCRSSRSLVHSRGNTYLHWYLQKPGQSPQLLIYKVSNRFIGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHLPFTFGQGTKLEIK,3,mild,,True,False,True,True,jain2017,0.8098172517111,8.797459757651835,10.398668885191348,0.8098172517111,19.952342859717294,0.11,9.635999999999996,10.936,9.082,500.0,0.1614,97.2774327422424,83.0,119,112,kappa,ZU,IgG4-CPPC,Approved,Yes,2011,,,8.797459757651835,10.398668885191348
lenzilumab,QVQLVQSGAEVKKPGASVKVSCKASGYSFTNYYIHWVRQAPGQRLEWMGWINAGNGNTKYSQKFQGRVTITRDTSASTAYMELSSLRSEDTAVYYCVRRQRFPYYFDYWGQGTLVTVSS,EIVLTQSPATLSVSPGERATLSCRASQSVGTNVAWYQQKPGQAPRVLIYSTSSRATGITDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQFNKSPLTFGGGTKVEIK,3,mild,,True,True,True,False,jain2017,0.6551284845893702,14.459031329082327,19.604658901830284,0.6551284845893702,29.64509490013043,0.02,10.121999999999998,8.722,8.605,0.0,0.03277,184.74275801653,74.0,119,107,kappa,HU,IgG1,Phase 2,Yes,2014,,,14.459031329082327,19.604658901830284
lintuzumab,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYNMHWVRQAPGQGLEWIGYIYPYNGGTGYNQKFKSKATITADESTNTAYMELSSLRSEDTAVYYCARGRPAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASESVDNYGISFMNWFQQKPGKAPKLLIYAASNQGSGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQSKEVPWTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.045706347729163,1.254575707154742,0.0,0.8859881084878957,-0.02,8.933000000000002,10.874,9.428,700.0,0.048,229.970847955366,75.5,116,111,kappa,ZU,IgG1,Phase 3,No,1996,,,1.045706347729163,1.254575707154742
lumiliximab,EVQLVESGGGLAKPGGSLRLSCAASGFRFTFNNYYMDWVRQAPGQGLEWVSRISSSGDPTWYADSVKGRFTISRENANNTLFLQMNSLRAEDTAVYYCASLTTGSDSWGQGVLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDIRYYLNWYQQKPGKAPKLLIYVASSLQSGVPSRFSGSGSGTEFTLTVSSLQPEDFATYYCLQVYSTPRTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.1448969343845078,1.1379105646124137,2.2183028286189685,0.1448969343845078,1.4435487891722294,-0.02,8.815,9.545,8.782,800.0,0.06686,86.2730393740933,64.5,118,107,kappa,XI,IgG1,Phase 2,No,2004,,,1.1379105646124137,2.2183028286189685
matuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSHWMHWVRQAPGQGLEWIGEFNPSNGRTNYNEKFKSKATMTVDTSTNTAYMELSSLRSEDTAVYYCASRDYDYDGRYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCSASSSVTYMYWYQQKPGKAPKLLIYDTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSHIFTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.0598553668783508,1.0276206322795345,0.0,-0.9272078922528316,-0.03,8.635,9.84,8.834,900.0,0.0164,224.328820629927,72.0,121,106,kappa,ZU,IgG1,Phase 2,No,2003,,,1.0598553668783508,1.0276206322795345
mavrilimumab,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSIHWVRQAPGKGLEWMGGFDPEENEIVYAQRFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCAIVGSFSPLTLGLWGQGTMVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSGSNIGAPYDVSWYQQLPGTAPKLLIYHNNKRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCATVEAGLSGSVFGGGTKLTVL,0,specific,0.0,False,False,False,False,jain2017,0.0,1.2130818227431417,2.161730449251248,0.0,-0.7787536595715207,-0.01,8.496,10.296,8.671,700.0,0.04903,150.548852590834,68.5,120,111,lambda,HU,IgG4,Phase 2,Yes,2009,,,1.2130818227431417,2.161730449251248
mepolizumab,QVTLRESGPALVKPTQTLTLTCTVSGFSLTSYSVHWVRQPPGKGLEWLGVIWASGGTDYNSALMSRLSISKDTSRNQVVLTMTNMDPVDTATYYCARDPPSSLLRLDYWGRGTPVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLAWYQQKPGQPPKLLIYGASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNVHSFPFTFGGGTKLEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.131191260106393,1.0515806988352745,0.0,-0.9566370687348312,-0.04,8.408,9.238,8.816,900.0,0.04451,221.475176577629,78.5,119,113,kappa,ZU,IgG1AA-mut,Approved,No,1999,,,1.131191260106393,1.0515806988352745
mogamulizumab,EVQLVESGGDLVQPGRSLRLSCAASGFIFSNYGMSWVRQAPGKGLEWVATISSASTYSYYPDSVKGRFTISRDNAKNSLYLQMNSLRVEDTALYYCGRHSDGNFAFGYWGQGTLVTVSS,DVLMTQSPLSLPVTPGEPASISCRSSRNIVHINGDTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSLLPWTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.1182820677553225,2.1657237936772047,0.0,-0.5117615211688626,-0.02,8.630999999999998,9.641,8.82,800.0,0.03631,89.7679294665026,68.5,119,112,kappa,ZU,IgG1-glyco,Approved,No,2010,,,1.1182820677553225,2.1657237936772047
muromonab,QVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPSRGYTNYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYWGQGTTLTVSS,QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPAHFRGSGSGTSYSLTISGMEAEDAATYYCQQWSSNPFTFGSGTKLEIK,0,specific,0.0,False,False,False,False,jain2017,0.1758916346908985,1.408897007528137,3.9374376039933447,0.1758916346908985,2.311512650397803,0.01,9.047999999999996,8.899,8.578,1000.0,0.03829,113.522880356409,74.5,119,106,kappa,XIa,IgG2a,Approved,No,1988,,,1.408897007528137,3.9374376039933447
natalizumab,QVQLVQSGAEVKKPGASVKVSCKASGFNIKDTYIHWVRQAPGQRLEWMGRIDPANGYTKYDPKFQGRVTITADTSASTAYMELSSLRSEDTAVYYCAREGYYGNYGVYAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKTSQDINKYMAWYQQTPGKAPRLLIHYTSALQPGIPSRFSGSGSGRDYTFTISSLQPEDIATYYCLQYDNLWTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.0639936735398734,1.5247920133111483,0.0,0.8228838815638237,-0.01,8.763999999999998,9.7,8.843,900.0,0.01877,251.745704994274,79.5,123,106,kappa,ZU,IgG4,Approved,No,1998,,,1.0639936735398734,1.5247920133111483
necitumumab,QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTDYNPSLKSRVTMSVDTSKNQFSLKVNSVTAADTAVYYCARVSIFGVGTFDYWGQGTLVTVSS,EIVMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQYGSTPLTFGGGTKAEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.045455831771032,1.3104825291181363,0.0,1.3005776956421913,-0.02,8.770999999999999,10.807,9.9,600.0,0.0204,198.599891054805,76.5,121,107,kappa,HU,IgG1,Approved,Yes,2008,,,1.045455831771032,1.3104825291181363
nivolumab,QVQLVESGGGVVQPGRSLRLDCKASGITFSNSGMHWVRQAPGKGLEWVAVIWYDGSKRYYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCATNDDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSSNWPRTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.1351754591387035,1.153877024631619,1.3244592346089852,0.1351754591387035,2.4180401288815534,-0.01,8.853,9.023,8.655,900.0,0.02743,178.809228510513,66.0,113,107,kappa,HU,IgG4-CPPC,Approved,No,2012,,,1.153877024631619,1.3244592346089852
obinutuzumab,QVQLVQSGAEVKKPGSSVKVSCKASGYAFSYSWINWVRQAPGQGLEWMGRIFPGDGDTDYNGKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNVFDGYWLVYWGQGTLVTVSS,DIVMTQTPLSLPVTPGEPASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCAQNLELPYTFGGGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.1127853019851912,0.9505575375720098,1.6295880149812734,0.1127853019851912,1.83157297498583,-0.01,8.799999999999999,10.641,8.964,600.0,0.0128,176.441448316105,73.0,119,112,kappa,ZU,IgG1-glyco,Approved,No,2009,,,0.9505575375720098,1.6295880149812734
ofatumumab,EVQLVESGGGLVQPGRSLRLSCAASGFTFNDYAMHWVRQAPGKGLEWVSTISWNSGSIGYADSVKGRFTISRDNAKKSLYLQMNSLRAEDTALYYCAKDIQYGNYYYGMDVWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPITFGQGTRLEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.1221425835603067,1.1767054908485857,0.0,1.2096991584336332,-0.02,9.248,9.729,9.524,800.0,0.02874,249.752167259925,68.0,122,107,kappa,HU,IgG1,Approved,No,2005,,,1.1221425835603067,1.1767054908485857
olokizumab,EVQLVESGGGLVQPGGSLRLSCAASGFNFNDYFMNWVRQAPGKGLEWVAQMRNKNYQYGTYYAESLEGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARESYYGFTSYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIGISLSWYQQKPGKAPKLLIYNANNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQHNSAPYTFGQGTKLEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.10536901058665,1.2292845257903493,0.0,-0.5026150619501847,-0.03,8.749,9.908,8.973,700.0,0.04469,115.258271448835,69.0,120,107,kappa,ZU,IgG4-CPPC,Phase 2,No,2010,,,1.10536901058665,1.2292845257903493
omalizumab,EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSLKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.116104955964963,1.1660565723793677,0.0,-0.4382784241093604,-0.02,8.537999999999998,9.519,8.744,800.0,0.04511,150.447109488797,77.5,121,111,kappa,ZU,IgG1,Approved,No,2000,,,1.116104955964963,1.1660565723793677
onartuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYWLHWVRQAPGKGLEWVGMIDPSNSDTRFNPNFKDRFTISADTSKNTAYLQMNSLRAEDTAVYYCATYRSYVTPLDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKSSQSLLYTSSQKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYAYPWTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.1192805146585436,1.1866888519134775,0.0,-0.0466620425648519,-0.02,8.911,9.919,8.869,800.0,0.04311,147.933138230081,80.0,119,113,kappa,ZU,IgG1-One-armed,Phase 3,No,2010,,,1.1192805146585436,1.1866888519134775
otlertuzumab,EVQLVQSGAEVKKPGESLKISCKGSGYSFTGYNMNWVRQMPGKGLEWMGNIDPYYGGTTYNRKFKGQVTISADKSISTAYLQWSSLKASDTAMYYCARSVGPFDSWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASENVYSYLAWYQQKPGQAPRLLIYFAKTLAEGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHHSDNPWTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.171753052308772,1.7816971713810317,0.0,2.2609834310984502,-0.03,9.516,10.959,10.267,600.0,0.07229,149.600653819379,68.5,116,107,kappa,ZU,scFv-Fc,Phase 2,No,2013,,,1.171753052308772,1.7816971713810317
ozanezumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVRQAPGQGLEWIGNINPSNGGTNYNEKFKSKATMTRDTSTSTAYMELSSLRSEDTAVYYCELMQGYWGQGTLVTVSS,DIVMTQSPLSNPVTLGQPVSISCRSSKSLLYKDGKTYLNWFLQRPGQSPQLLIYLMSTRASGVPDRFSGGGSGTDFTLKISRVEAEDVGVYYCQQLVEYPLTFGQGTKLEIK,3,mild,,True,True,True,False,jain2017,0.7713140231818809,2.0293580052025075,4.452579034941763,0.7713140231818809,27.692332066403335,0.45,9.045999999999998,10.034,8.632,0.0,0.05569,97.0746878906631,67.0,113,112,kappa,ZU,IgG1,Phase 2,No,2012,,,2.0293580052025075,4.452579034941763
palivizumab,QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMSVGWIRQPPGKALEWLADIWWDDKKDYNPSLKSRLTISKDTSKNQVVLKVTNMDPADTATYYCARSMITNWYFDVWGAGTTVTVSS,DIQMTQSPSTLSASVGDRVTITCKCQLSVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKLEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.11884672778966,2.876539101497504,0.0,-0.852684669073482,-0.03,8.490999999999998,9.332,8.705,900.0,0.03666,243.119697931277,79.5,120,106,kappa,ZU,IgG1,Approved,No,1998,,,1.11884672778966,2.876539101497504
panitumumab,QVQLQESGPGLVKPSETLSLTCTVSGGSVSSGDYYWTWIRQSPGKGLEWIGHIYYSGNTNYNPSLKSRLTISIDTSKTQFSLKLSSVTAADTAIYYCVRDRVTGAFDIWGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYFCQHFDHLPLAFGGGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.0620884253110507,1.1826955074875207,0.0,-1.0846051804108647,-0.03,8.42,9.479,8.799,900.0,0.03631,179.58785735722,78.5,119,107,kappa,HU,IgG2,Approved,No,2004,,,1.0620884253110507,1.1826955074875207
panobacumab,EEQVVESGGGFVQPGGSLRLSCAASGFTFSPYWMHWVRQAPGKGLVWVSRINSDGSTYYADSVKGRFTISRDNARNTLYLQMNSLRAEDTAVYYCARDRYYGPEMWGQGTMVTVSS,DVVMTQSPLSLPVTLGQPASISCRSSQSLVYSDGNTYLNWFQQRPGQSPRRLIYKVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPLTFGGGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.212666778322873,1.896838602329451,0.0,-0.4155766600895652,-0.01,8.992000000000003,9.827,8.85,900.0,0.02071,107.597685805881,69.0,116,112,kappa,HU,IgM,Phase 2,No,2008,,,1.212666778322873,1.896838602329451
parsatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYTFIDYYMNWVRQAPGKGLEWVGDINLDNSGTHYNQKFKGRFTISRDKSKNTAYLQMNSLRAEDTAVYYCAREGVYHDYDDYAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRTSQSLVHINAITYLHWYQQKPGKAPKLLIYRVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCGQSTHVPLTFGQGTKVEIK,3,mild,,True,False,True,True,jain2017,0.1344436107271991,10.046526919824307,17.395673876871882,0.1344436107271991,7.400358629404036,0.12,8.650999999999998,9.109,8.781,900.0,0.08654,40.0193274662591,64.5,123,112,kappa,ZU,IgG1,Phase 2,Yes,2012,,,10.046526919824307,17.395673876871882
pertuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFTDYTMDWVRQAPGKGLEWVADVNPNSGGSIYNQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYIYPYTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.2135825800677662,1.691846921797005,0.0,-0.2038247903172226,-0.04,8.597,10.112,8.913,700.0,0.03917,31.426915083696,78.5,119,107,kappa,ZU,IgG1,Approved,No,2003,,,1.2135825800677662,1.691846921797005
pinatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYEFSRSWMNWVRQAPGKGLEWVGRIYPGDGDTNYSGKFKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARDGSSWDWYFDVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRSSQSIVHSVGNTFLEWYQQKPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFQGSQFPYTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0113662831220609,1.2721713049670622,2.4851913477537435,0.0113662831220609,0.5895214803654546,-0.02,8.774000000000001,9.224,8.827,800.0,0.06846,130.580856755494,79.0,120,112,kappa,ZU,IgG1-ADC,Phase 2,No,2012,,,1.2721713049670622,2.4851913477537435
polatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGYTFSSYWIEWVRQAPGKGLEWIGEILPGGGDTNYNEIFKGRATFSADTSKNTAYLQMNSLRAEDTAVYYCTRRVPIRLDYWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCKASQSVDYEGDSFLNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPLTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.3625371953152638,3.622628951747088,0.0,-1.0031675074379405,-0.05,8.263999999999998,8.763,8.67,1000.0,0.05931,225.055164066148,74.0,117,111,kappa,ZU,IgG1,Phase 2,Yes,2012,,,1.3625371953152638,3.622628951747088
radretumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSFSMSWVRQAPGKGLEWVSSISGSSGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKPFPYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFLAWYQQKPGQAPRLLIYYASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQTGRIPPTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.1336773168637967,1.259503881510183,3.286522462562396,0.1336773168637967,3.38469852929544,0.0,8.858000000000002,9.514,8.69,900.0,0.001743,151.171797090559,77.0,116,108,kappa,HU,scFv-CH,Phase 2,Yes,2010,,,1.259503881510183,3.286522462562396
ramucirumab,EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVTDAFDIWGQGTMVTVSS,DIQMTQSPSSVSASIGDRVTITCRASQGIDNWLGWYQQKPGKAPKLLIYDASNLDTGVPSRFSGSGSGTYFTLTISSLQAEDFAVYFCQQAKAFPPTFGGGTKVDIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.0548930060222366,1.2499168053244594,0.0,0.0158442816167506,-0.02,8.581999999999999,9.43,8.705,900.0,0.02434,90.6680959632434,66.0,116,107,kappa,HU,IgG1,Approved,Yes,2008,,,1.0548930060222366,1.2499168053244594
ranibizumab,EVQLVESGGGLVQPGGSLRLSCAASGYDFTHYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPYYYGTSHWYFDVWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIK,3,mild,,True,True,False,True,jain2017,0.0,1.6071237071180915,3.1381031613976704,0.0,7.925273438937659,0.02,10.057999999999998,12.142,18.059,300.0,0.0942,41.4478661761276,65.0,123,107,kappa,ZU,Fab,Approved,Yes,2004,,,1.6071237071180915,3.1381031613976704
reslizumab,EVQLVESGGGLVQPGGSLRLSCAVSGLSLTSNSVNWIRQAPGKGLEWVGLIWSNGDTDYNSAIKSRFTISRDTSKSTVYLQMNSLRAEDTAVYYCAREYYGYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCLASEGISSYLAWYQQKPGKAPKLLIYGANSLQTGVPSRFSGSGSATDYTLTISSLQPEDFATYYCQQSYKFPNTFGQGTKVEVK,0,specific,0.0,False,False,False,False,jain2017,0.2302901027079426,1.2514632393209744,2.0232945091514143,0.2302901027079426,1.7393013527342458,0.0,8.863999999999999,9.824,8.9,700.0,0.06217,191.56852636743,75.5,116,107,kappa,ZU,IgG4,Approved,No,2001,,,1.2514632393209744,2.0232945091514143
rilotumumab,QVQLQESGPGLVKPSETLSLTCTVSGGSISIYYWSWIRQPPGKGLEWIGYVYYSGSTNYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYYCARGGYDFWSGYFDYWGQGTLVTVSS,EIVMTQSPATLSVSPGERATLSCRASQSVDSNLAWYRQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYINWPPITFGQGTRLEIK,3,mild,,True,True,False,True,jain2017,0.1600219342634753,1.130870798292275,2.3730337078651687,0.1600219342634753,2.126579585174486,0.0,10.393,12.633,17.684,500.0,1.2728,173.0777953220001,79.0,120,108,kappa,HU,IgG2,Phase 3,No,2009,,,1.130870798292275,2.3730337078651687
robatumumab,EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWISVIDTRGATYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGNFYYGMDVWGQGTTVTVSS,EIVLTQSPGTLSVSPGERATLSCRASQSIGSSLHWYQQKPGQAPRLLIKYASQSLSGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCHQSSRLPHTFGQGTKVEIK,3,mild,,True,True,True,False,jain2017,0.2666565076523404,5.219351315649218,8.246256239600665,0.2666565076523404,29.64509490013043,0.14,9.752,9.507,8.969,0.0,0.04534,117.115691209503,80.0,118,107,kappa,HU,IgG1,Phase 2,No,2008,,,5.219351315649218,8.246256239600665
romosozumab,EVQLVQSGAEVKKPGASVKVSCKASGYTFTDYNMHWVRQAPGQGLEWMGEINPNSGGAGYNQKFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARLGYDDIYDDWYFDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSRLLSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGDTLPYTFGGGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.0073451432896825,1.4682196339434277,0.0,-1.019466113704991,-0.03,8.426999999999998,9.18,8.648,1000.0,0.02831,227.687243355563,76.0,123,107,kappa,ZU,IgG2,Phase 3,No,2011,,,1.0073451432896825,1.4682196339434277
sarilumab,EVQLVESGGGLVQPGRSLRLSCAASRFTFDDYAMHWVRQAPGKGLEWVSGISWNSGRIGYADSVKGRFTISRDNAENSLFLQMNGLRAEDTALYYCAKGRDSFDIWGQGTMVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFASYYCQQANSFPYTFGQGTKLEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.1869120226240375,2.16838602329451,0.0,1.1138239186948329,-0.01,8.71,8.989,8.687,900.0,0.04986,181.786077494252,64.0,116,107,kappa,HU,IgG1,Phase 3,No,2011,,,1.1869120226240375,2.16838602329451
secukinumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWMNWVRQAPGKGLEWVAAINQDGSEKYYVGSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCVRDYYDILTDYYIHYWYFDLWGRGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPCTFGQGTRLEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.0888623977969765,1.694756554307116,0.0,-0.5847129696615325,-0.04,8.360999999999999,11.389,8.906,800.0,0.0492,148.958795741179,72.0,127,108,kappa,HU,IgG1,Approved,No,2009,,,1.0888623977969765,1.694756554307116
seribantumab,EVQLLESGGGLVQPGGSLRLSCAASGFTFSHYVMAWVRQAPGKGLEWVSSISSSGGWTLYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRGLKMATIFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNVVSWYQQHPGKAPKLIIYEVSQRPSGVSNRFSGSKSGNTASLTISGLQTEDEADYYCCSYAGSSIFVIFGGGTKVTVL,3,mild,,True,True,False,True,jain2017,0.0,1.2374308746890108,2.9737104825291185,0.0,21.20826376243033,0.01,9.787,10.418,8.998,300.0,0.1544,189.983139937075,77.5,119,111,lambda,HU,IgG2,Phase 2,Yes,2012,,,1.2374308746890108,2.9737104825291185
siltuximab,EVQLVESGGKLLKPGGSLKLSCAASGFTFSSFAMSWFRQSPEKRLEWVAEISSGGSYTYYPDTVTGRFTISRDNAKNTLYLEMSSLRSEDTAMYYCARGLWGYYALDYWGQGTSVTVSS,QIVLIQSPAIMSASPGEKVTMTCSASSSVSYMYWYQQKPGSSPRLLIYDTSNLASGVPVRFSGSGSGTSYSLTISRMEAEDAATYYCQQWSGYPYTFGGGTKLEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.1753257510105992,1.5498127340823968,0.0,2.63765782682196,-0.01,9.419999999999998,10.999,12.076,600.0,0.0133,95.6671732503288,64.5,119,106,kappa,XI,IgG1,Approved,No,2008,,,1.1753257510105992,1.5498127340823968
simtuzumab,QVQLVQSGAEVKKPGASVKVSCKASGYAFTYYLIEWVRQAPGQGLEWIGVINPGSGGTNYNEKFKGRATITADKSTSTAYMELSSLRSEDTAVYFCARNWMNFDYWGQGTTVTVSS,DIVMTQTPLSLSVTPGQPASISCRSSKSLLHSNGNTYLYWFLQKPGQSPQFLIYRMSNLASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQHLEYPYTFGGGTKVEIK,3,mild,,True,False,True,True,jain2017,0.3368752194611134,6.008055924888647,10.411314475873544,0.3368752194611134,0.8806858247165398,0.0,9.098,10.407,9.571,800.0,0.1421,191.43536575903,66.5,116,112,kappa,ZU,IgG4-CPPC,Phase 2,No,2012,,,6.008055924888647,10.411314475873544
sirukumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSPFAMSWVRQAPGKGLEWVAKISPGGSWTYYSDTVTGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQLWGYYALDIWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCSASISVSYMYWYQQKPGQAPRLLIYDMSNLASGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCMQWSGYPYTFGGGTKVEIK,3,mild,,True,True,True,False,jain2017,0.3598739363069841,2.1745394240741476,9.657903494176374,0.3598739363069841,29.64509490013043,0.08,10.79,11.26,10.756,0.0,0.03969,109.80671187862,68.0,119,106,kappa,HU,IgG1,Phase 3,Yes,2011,,,2.1745394240741476,9.657903494176374
tabalumab,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGYYDILTGYYYYFDYWGQGTLVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDSTLTISSLEPEDFAVYYCQQRSNWPRTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.2603857827328724,3.6818635607321126,0.0,1.9553606921790136,-0.01,9.126999999999995,10.847,9.87,700.0,0.0618,121.595499055525,64.0,123,107,kappa,HU,IgG4-CPPC,Phase 3,No,2011,,,1.2603857827328724,3.6818635607321126
tigatuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYVMSWVRQAPGKGLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARRGDSMITTDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSSYRTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.1287699032014038,1.1729393976465865,1.702621722846442,0.1287699032014038,5.48928624336508,-0.01,8.7,10.02,8.732,700.0,0.0029,178.9678004885262,64.5,119,106,kappa,ZU,IgG1,Phase 2,No,2007,,,1.1729393976465865,1.702621722846442
tildrakizumab,QVQLVQSGAEVKKPGASVKVSCKASGYIFITYWMTWVRQAPGQGLEWMGQIFPASGSADYNEKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGGGFAYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRTSENIYSYLAWYQQKPGKAPKLLIYNAKTLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYGIPFTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.1862533869555876,1.7690515806988354,0.0,0.8149033177938515,-0.01,8.727999999999996,11.079,9.868,600.0,-0.005,181.888072908582,77.5,116,107,kappa,ZU,IgG1,Phase 3,No,2012,,,1.1862533869555876,1.7690515806988354
tocilizumab,QVQLQESGPGLVRPSQTLSLTCTVSGYSITSDHAWSWVRQPPGRGLEWIGYISYSGITTYNPSLKSRVTMLRDTSKNQFSLRLSSVTAADTAVYYCARSLARTTAMDYWGQGSLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDISSYLNWYQQKPGKAPKLLIYYTSRLHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQGNTLPYTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.135550122276806,2.8079866888519134,0.0,1.3182827059504585,0.0,8.902,9.088,8.777,900.0,0.04516,139.649467055541,91.5,119,107,kappa,ZU,IgG1,Approved,No,2004,,,1.135550122276806,2.8079866888519134
tovetumab,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMNWIRQAPGKGLEWVSYISSSGSIIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGRIAARGMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVSITCRPSQSFSRYINWYQQKPGKAPKLLIHAASSLVGGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYSNPPITFGQGTRLEMK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.3521453590768024,2.951685393258427,0.0,2.24515352101381,-0.01,8.808,8.673,8.634,900.0,0.0131,277.1807519763495,63.5,120,108,kappa,HU,IgG2,Phase 2,No,2013,,,1.3521453590768024,2.951685393258427
trastuzumab,EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.063454607533758,1.3364392678868553,0.0,2.0381268958261267,-0.02,8.843000000000002,9.657,8.752,800.0,0.04383,159.477626783881,78.5,120,107,kappa,ZU,IgG1,Approved,No,1997,,,1.063454607533758,1.3364392678868553
vedolizumab,QVQLVQSGAEVKKPGASVKVSCKGSGYTFTSYWMHWVRQAPGQRLEWIGEIDPSESNTNYNQKFKGRVTLTVDISASTAYMELSSLRSEDTAVYYCARGGYDGWDYAIDYWGQGTLVTVSS,DVVMTQSPLSLPVTPGEPASISCRSSQSLAKSYGNTYLSWYLQKPGQSPQLLIYGISNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQGTHQPYTFGQGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.1526713187714972,1.584026622296173,0.0,0.3881784429681827,-0.02,8.986,10.942,12.307,600.0,0.06906,221.762037454388,80.5,121,112,kappa,ZU,IgG1AA-mut,Approved,No,2008,,,1.1526713187714972,1.584026622296173
veltuzumab,QVQLQQSGAEVKKPGSSVKVSCKASGYTFTSYNMHWVKQAPGQGLEWIGAIYPGMGDTSYNQKFKGKATLTADESTNTAYMELSSLRSEDTAFYYCARSTYYGGDWYFDVWGQGTTVTVSS,DIQLTQSPSSLSASVGDRVTMTCRASSSVSYIHWFQQKPGKAPKPWIYATSNLASGVPVRFSGSGSGTDYTFTISSLQPEDIATYYCQQWTSNPPTFGGGTKLEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,0.8888091523389052,1.2112359550561798,0.0,4.831871310872237,-0.02,8.791999999999998,11.092,9.725,700.0,0.0399,224.9535174226083,70.0,121,106,kappa,ZU,IgG1,Phase 2,No,2007,,,0.8888091523389052,1.2112359550561798
visilizumab,QVQLVQSGAEVKKPGASVKVSCKASGYTFISYTMHWVRQAPGQGLEWMGYINPRSGYTHYNQKLKDKATLTADKSASTAYMELSSLRSEDTAVYYCARSAYYDYDGFAYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCSASSSVSYMNWYQQKPGKAPKRLIYDTSKLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQWSSNPPTFGGGTKVEIK,3,mild,,True,True,True,False,jain2017,0.4180705492837355,1.8807718205977448,4.799334442595674,0.4180705492837355,21.988193058351637,0.01,9.146,9.007,8.695,0.0,0.0576,242.006376767476,71.0,120,106,kappa,ZU,IgG2,Phase 3,No,2000,,,1.8807718205977448,4.799334442595674
zalutumumab,QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVIWDDGSYKYYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGITMVRGVMKDYFDYWGQGTLVTVSS,AIQLTQSPSSLSASVGDRVTITCRASQDISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSESGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK,0,specific,0.0,False,False,False,False,jain2017,0.0,1.2843634959160908,2.896505823627288,0.0,-0.796790150018558,-0.03,8.414999999999997,9.335,8.738,900.0,0.04983,200.506689606493,72.5,125,107,kappa,HU,IgG1,Phase 3,No,2005,,,1.2843634959160908,2.896505823627288
zanolimumab,QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARVINWFDPWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQDISSWLAWYQHKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPYTFGQGTKLEIK,0,specific,0.0,False,False,False,False,jain2017,0.1271277252105276,1.1022619931841997,1.4555740432612314,0.1271277252105276,1.4579366607851665,-0.01,8.609999999999998,9.586,8.768,700.0,0.02569,116.367687863994,80.5,115,107,kappa,HU,IgG1,Phase 3,No,2004,,,1.1022619931841997,1.4555740432612314
